FDA Action on Unapproved GLP-1s The FDA has documented more than 1,000 adverse events linked to compounded semaglutide and tirzepatide products, including cases of fraud and dosing errors
GLP-1R/GIPR GLP-1R (glucagon-like peptide-1 receptor) is a Class B G-protein-coupled receptor (GPCR) expressed in various tissues and organs, including pancreatic -cells, the stomach, small intestine, heart, kidneys, lungs, and brain
2023;101:skac428
They offer cost-effective treatment options because they can self-amplify and autonomously produce therapeutic agents
By constructing a network linking drugs, targets, and diseases, researchers can uncover how Chinese medicine components exert antidepressant effects
Note: If you notice the liquid in your vial has become cloudy, discolored, or contains visible particles, do not use it